About this episode
P.M. Edition for Aug. 19. Today the total U.S. debt passed $40 trillion. WSJ economics reporter Matt Grossman discusses what that means for how the government functions. Plus, a successful trial of a mRNA vaccine for melanoma could mean potential new treatments for a deadly cancer–and news of the trial results more than doubled Moderna’s stock price. And the Federal Trade Commission says retailers have to let shoppers know when they’re using their personal data to raise prices. Dave Michaels, who covers corporate law enforcement for the Journal, explains how personalized pricing works, and how the FTC is looking to rein it in. Alex Ossola hosts.
How Governments in the U.S. and Europe Are Stalling the AI Buildout
Sign up for the WSJ's free What's News newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ What’s News publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ What’s News
Inside Pete Hegseth’s Pentagon Shake-Up
WSJ What’s News
What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
WSJ What’s News
Inflation Held Steady in August, Pushing the Fed Towards a Rate Hike
WSJ What’s News
Did J.D. Vance Just Make His 2028 Pitch?
WSJ What’s News